CSIMarket
 


Aratana Therapeutics, Inc.  (PETX)
Other Ticker:  
 
 

PETX's EPS Net Growth by Quarter and Year

Aratana Therapeutics,'s EPS Net results by quarter and year




PETX EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -0.18 -0.37 -0.38
III Quarter September - 0.19 -0.21 0.61
II Quarter June - -0.14 -0.26 -0.52
I Quarter March -0.14 -0.19 -0.34 -0.37
FY   -0.14 -0.32 -1.18 -0.66



PETX EPS Net first quarter 2019 Y/Y Growth Comment
Aratana Therapeutics, Inc. in the first quarter 2019 recorded EPS net loss of $ -0.14 .

According to the results reported in the first quarter 2019, Aratana Therapeutics, Inc. achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Aratana Therapeutics, Inc.' s EPS Net no change of % ranks overall at the positon no. in the first quarter 2019.




PETX EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Aratana Therapeutics,'s first quarter 2019 EPS Net $ -0.14 PETX's Income Statement
Aratana Therapeutics,'s first quarter 2018 EPS Net $ -0.19 Quarterly PETX's Income Statement
New: More PETX's historic EPS Net Growth >>


PETX EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Aratana Therapeutics,'s Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PETX's I. Quarter Q/Q EPS Net Comment
Although Aratana Therapeutics, Inc. in the I. Quarter 2019 admitted EPS net loss of $ -0.14 , management point out, that current results are recovery in contrast to the -0.18 in the fourth quarter.

Within Major Pharmaceutical Preparations industry Aratana Therapeutics, Inc. achieved highest sequential EPS Net growth. While Aratana Therapeutics,'s EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PETX's I. Quarter Q/Q EPS Net Comment
Even if Aratana Therapeutics, Inc. in the I. Quarter 2019 revealed EPS net loss of $ -0.14 , it should be said, that this point to improvement in contrast to the -0.18 in the fourth quarter.

Within Major Pharmaceutical Preparations industry Aratana Therapeutics, Inc. achieved highest sequential EPS Net growth. While Aratana Therapeutics,'s EPS Net growth quarter on quarter, overall rank is .


Aratana Therapeutics,'s 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
Cumulative EPS Net 12 Months Ending $ -0.27 $ -0.32 $ -0.51 $ -0.91 $ -1.03
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment


Aratana Therapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment


Aratana Therapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
PETX's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for PETX's Competitors
EPS Net Growth for Aratana Therapeutics,'s Suppliers
EPS Net Growth for PETX's Customers

You may also want to know
PETX's Annual Growth Rates PETX's Profitability Ratios PETX's Asset Turnover Ratio PETX's Dividend Growth
PETX's Roe PETX's Valuation Ratios PETX's Financial Strength Ratios PETX's Dividend Payout Ratio
PETX's Roa PETX's Inventory Turnover Ratio PETX's Growth Rates PETX's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2019
Amgen Inc -2.15%$ -2.154 
Resmed Inc -3.95%$ -3.947 
Regeneron Pharmaceuticals Inc -4.09%$ -4.087 
Abbvie inc -5.17%$ -5.172 
Quest Diagnostics Inc-5.51%$ -5.512 
Stryker Corp-6.03%$ -6.034 
Hca Healthcare Inc -6.60%$ -6.604 
Baxter International Inc -7.04%$ -7.042 
Davita Inc -8.16%$ -8.163 
Iqvia Holdings Inc -9.38%$ -9.375 
Zoetis Inc -9.72%$ -9.722 
Lemaitre Vascular Inc -10.53%$ -10.526 
Addus Homecare Corporation-14.29%$ -14.286 
Globus Medical Inc -15.38%$ -15.385 
Perrigo Company Plc-17.54%$ -17.544 
Lannett Company Inc-18.18%$ -18.182 
Pacific Health Care Organization Inc -18.18%$ -18.182 
Surmodics Inc-18.18%$ -18.182 
Henry Schein Inc-19.78%$ -19.780 
Utah Medical Products Inc-22.94%$ -22.936 
Phibro Animal Health Corporation-24.49%$ -24.490 
American Shared Hospital Services-28.57%$ -28.571 
Msa Safety Incorporated-28.92%$ -28.916 
Quidelortho Corp-30.23%$ -30.233 
Supernus Pharmaceuticals inc -30.61%$ -30.612 
Exelixis Inc -35.14%$ -35.135 
Acadia Healthcare Company Inc -41.38%$ -41.379 
Myriad Genetics Inc -43.75%$ -43.750 
Molecular Templates inc -46.88%$ -46.875 
Inogen Inc -50.00%$ -50.000 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com